Selection of reference genes for studies of human retinal endothelial cell gene expression by reverse transcriptionquantitative real-time polymerase chain reaction by Appukuttan, Binoy et al.
Archived at the Flinders Academic Commons: 
http://dspace.flinders.edu.au/dspace/ 
‘This is the peer reviewed version of the following article: 
Appukuttan, B., Ashander, L. M., Ma, Y., & Smith, J. R. 
(2018). Selection of reference genes for studies of human 
retinal endothelial cell gene expression by reverse 
transcription-quantitative real-time polymerase chain 
reaction. Gene Reports, 10, 123–134. https://
doi.org/10.1016/j.genrep.2017.11.009 
which has been published in final form at 
http://dx.doi.org/10.1016/j.genrep.2017.11.009
© 2017 Elsevier. This manuscript version is made 
available under the CC-BY-NC-ND 4.0 license:
http://creativecommons.org/licenses/by-nc-nd/4.0/ 
Accepted Manuscript
Selection of reference genes for studies of human retinal
endothelial cell gene expression by reverse transcription-
quantitative real-time polymerase chain reaction





To appear in: Gene Reports
Received date: 3 October 2017
Revised date: 10 November 2017
Accepted date: 21 November 2017
Please cite this article as: Binoy Appukuttan, Liam M. Ashander, Yuefang Ma, Justine
R. Smith , Selection of reference genes for studies of human retinal endothelial cell gene
expression by reverse transcription-quantitative real-time polymerase chain reaction. The
address for the corresponding author was captured as affiliation for all authors. Please
check if appropriate. Genrep(2017), doi:10.1016/j.genrep.2017.11.009
This is a PDF file of an unedited manuscript that has been accepted for publication. As
a service to our customers we are providing this early version of the manuscript. The
manuscript will undergo copyediting, typesetting, and review of the resulting proof before
it is published in its final form. Please note that during the production process errors may















Selection of Reference Genes for Studies of Human Retinal Endothelial Cell Gene 
Expression by Reverse Transcription-Quantitative Real-Time Polymerase Chain 
Reaction  
 
Binoy Appukuttan, PhD 
Liam M. Ashander, BS 
Yuefang Ma, PhD  
Justine R. Smith, FRANZCO, PhD  
 










Corresponding Author:  
Binoy Appukuttan, PhD  
Address: Eye & Vision Health, Flinders University College of Medicine and Public Health, 



















Background: Human retinal endothelial cells are employed increasingly for 
investigations of retinal vascular diseases. Analysis of gene expression response to 
disease-associated stimuli by reverse transcription-quantitative real-time polymerase 
chain reaction (RT-qPCR) is common. However, most reported work does not follow the 
minimum information for publication of qPCR experiments (MIQE) recommendation 
that multiple, stably expressed reference genes be used for normalization. 
 
Methods: Two human retinal endothelial cell lines were treated with medium alone or 
containing stimuli that included: glucose at supraphysiological concentration, 
dimethyloxalyl-glycine, vascular endothelial growth factor, tumor necrosis factor-α, 
lipopolysaccharide and Toxoplasma gondii tachyzoites. Biological response of cells was 
confirmed by measuring significant increase in a stimulus-relevant transcript. Total RNA 
was reverse transcribed and analyzed by commercial PCR arrays designed to detect 28 
reference genes. Stability of reference gene expression, for each and both cell lines, and 
for each and all conditions, was judged on gene-stability measure (M-value) less than 0.2 
and coefficient of variation (CV-value) less than 0.1. 
 
Results: Reference gene expression varied substantially across stimulations and 
between cell lines. Of 27 detectable reference genes, 11-21 (41-78%) maintained 
expression stability across stimuli and cell lines. Ranking indicated substantial diversity 
in the most stable reference genes under different conditions, and no reference gene 















reference genes were expressed stably under 5 conditions: HSP90AB1, IPO8, PSMC4 and 
RPLPO.  
 
Conclusions: We observed variation in stability of reference gene expression with 
different stimuli and between human retinal endothelial cell lines. Our findings support 
adherence to MIQE recommendations regarding normalization in RT-qPCR studies of 
human retinal endothelial cells. 
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Diseases that involve the endothelium of the retinal vasculature are leading causes of 
impaired vision and blindness across the world: diabetic retinopathy; central retinal 
vein occlusion; retinopathy of prematurity; immune-mediated posterior uveitis; and 
ocular toxoplasmosis.1 In these conditions, endothelial cell dysfunction contributes to 
retinal vascular leakage, neovascularization and/or leukocytic or microbial infiltration. 
Consequently, human retinal endothelial cells are the subject of multiple in vitro studies 
of basic pathogenic mechanisms. Independent research groups – including our own – 
isolate primary retinal endothelial cells from human cadaveric eyes2,3 or purchase cells 
from commercial sources4,5 to undertake these studies, which commonly involve 
analysis by reverse transcription-quantitative real-time polymerase chain reaction  
(RT-qPCR).    
 
Since its introduction over 20 years ago as a method for quantifying differences in gene 
expression between experimental conditions,6 RT-qPCR has become a standard and 
common tool in molecular research and diagnostics. Although RT-qPCR is a robust 
technique, methodological variations may profoundly impact output, with implications 
for interpretation and reproducibility of results across laboratories. The minimum 
information for publication of qPCR experiments (MIQE) guidelines were first proposed 
in 2009, to improve communication in reporting and also provide methodological 
standards for performing qPCR.7 One important consideration for compliance with the 
MIQE guidelines is the selection of endogenous reference genes – previously generically 
referred to as housekeeping genes – for normalization of mRNA concentrations. The 















all samples, regardless of source and/or environment, and further, strongly recommend 
multiple reference genes be employed for any normalization.7    
 
To identify reference genes for MIQE-compliant RT-qPCR studies of human retinal 
endothelial cells, we exposed cell lines derived from retinae of two different human 
donors to stimuli commonly used to elicit disease-relevant responses: (1) glucose at 
supraphysiological concentration, which is the central abnormality in diabetes mellitus; 
(2) hypoxia simulator, dimethyloxalylglycine (DMOG); (3) key regulator of 
neovascularization, vascular endothelial growth factor (VEGFA); (4) master 
inflammatory cytokine, tumor necrosis factor (TNF)-α; (5) bacterial component, 
lipopolysaccharide (LPS); and (6) the cause of ocular toxoplasmosis, Toxoplasma gondii 
tachyzoites. We used PCR array profiling to interrogate expression of 28 reference genes 
in the cell lines. Our results show that human retinal endothelial cells transcribe a 
majority of reference genes stably under different conditions, but the exceptions to this 
finding vary with the stimulus and the cell population. 
 
Materials and Methods 
 
Overview of experimental design 
Triplicate human retinal endothelial cell cultures were treated with medium only or one 
of six molecular or microbial stimuli that included: (1) glucose at supraphysiological 
concentration; (2) DMOG; (3) VEGFA; (4) TNF-α; (5) LPS; and (6) T. gondii tachyzoites. 
Total RNA was extracted from lysate prepared from each culture, and high quality of the 
RNA was verified. From every RNA preparation, cDNA was synthesized and separately 















stimulus was confirmed on the same RNA samples by RT-qPCR measurement of a 
stimulus-relevant transcript: (1) glucose at supraphysiological concentration, 
interleukin 1β (IL-1β); (2) DMOG, VEGFA; (3) VEGFA, Down syndrome critical region 
gene 1 (DSCR1); (4) TNF-α, intercellular adhesion molecule 1 (ICAM-1); (5) LPS, ICAM-
1; and (6) T. gondii tachyzoites, suppressor of cytokine signaling 1 (SOCS1). Two 
human retinal endothelial cell lines, generated from eyes of two human cadaveric 
donors, were studied separately. 
 
Endothelial cell and microbial culture  
Our method for generating human retinal endothelial cell lines has been published.1 In 
summary, endothelial cells were isolated from paired human cadaver retinae 
(VisionGift, Portland, OR) by enzymatic digestion of tissue and selection with magnetic 
bead-conjugated anti-human CD31 antibody, and subsequently expanded by 
transduction with the mouse recombinant amphotropic retrovirus, LXSN16E6E7.8 These 
cell lines retain their endothelial phenotype, including expression of endothelial 
markers and formation of capillary-like tubes on Matrigel,1 and they have been used in 
multiple published studies of retinal vascular disease (e.g.9-11). Human retinal 
endothelial cells were cultured in MCDB-131 medium (Sigma-Aldrich, St. Louis, MO; 
catalogue numberM8537), supplemented with 10% heat-inactivated fetal bovine serum 
(FBS) (HyClone-GE Healthcare Life Sciences, Logan, UT) and endothelial growth factors 
(EGM-2 SingleQuots supplement, omitting FBS, hydrocortisone and gentamicin; 
Clonetics-Lonza, Walkersville, MD) at 37 °C and 5% CO2 in air. 
 
GT-1 strain T. gondii were maintained in tachyzoite form by serial passage in confluent 















(DMEM; Catalogue number, 12100; Life Technologies-Gibco, Grand Island, NY), 
supplemented with 44 mM sodium bicarbonate and 1% FBS, at 37 C and at 5% CO2 in 
air. Plaque assays were performed using human fibroblast monolayers to verify parasite 
viability for each retinal endothelial cell infection: viability of 15% or greater was 
required, consistent with published measurements for a natural isolate.12  
 
Reagents and proteins 
D-Glucose was supplemented to a concentration of 30 mM. Dimethyloxalylglycine 
(Sigma-Aldrich; catalogue number D3695) was used at a working concentration of  
1 mM. Recombinant human VEGFA (VEGF165) and TNF-α (both from R&D Systems, 
Minneapolis, MN; catalogue numbers 293-VE-010 and 210-TA-020) were used at 
working concentrations of 10 ng/mL and 25 ng/mL, respectively. Lipopolysaccharide 
from Escherichia coli 055:B5 (Sigma-Aldrich; catalogue number L6529) was used at a 
working concentration of 10 μg/mL. 
 
Stimulation of human retinal endothelial cells 
Human retinal endothelial cells were grown to confluence in 6-well plates, in modified 
MCDB-131 medium with 10% FBS and endothelial growth factors. Three monolayers on 
each plate were treated with one stimulus in fresh medium (i.e., glucose, DMOG, VEGFA, 
LPS, TNF-α and T. gondii: 2.5 x 106 freshly egressed tachyzoites per well) and the three 
remaining monolayers were treated with fresh medium alone. In the case of the T. gondii 
stimulations, FBS in the medium was reduced to 5%, to minimize effects of serum 
components on parasite viability. Cell monolayers were incubated for 4 hours at 37 °C 
and 5% CO2 in air ahead of RNA extraction, with the exception of cells treated with 















stimulus indicated no biological response at 4 hours (data not shown), and therefore 
incubation was extended to 24 hours.  
 
RNA isolation and reverse transcription 
Retinal endothelial cell monolayers were covered with Buffer RLT (Qiagen, Hilden, 
Germany) containing 0.55 mM β-mercaptoethanol (Sigma-Aldrich), and cell lysates were 
frozen at -80 °C ahead of RNA extraction. Total RNA was extracted using the RNeasy 
mini kit (Qiagen), according to the manufacturer’s instructions and including the on-
column DNase treatment. RNA concentration, purity and quality were determined by 
nanodrop spectrophotometry (NanoDrop 2000c, Thermo Scientific, Wilmington, DE) 
and chip-based capillary electrophoresis on the Agilent 2100 Bioanalyzer system 
(Agilent Technologies, Waldbronn, Germany). Only highly pure RNA, with A260/280 
ratios greater than 1.8 and RNA integrity numbers over 9.0, was used for qPCR. Reverse 
transcription was performed using the iScript Reverse Transcription Supermix for RT-
qPCR (Bio-Rad, Hercules, CA), with 500 ng RNA template per 20 μl RT reaction mix, 
yielding 25 ng/μl cDNA. For each RNA template, four 20 μl RT reactions were performed 
and cDNA was pooled, to minimize inefficiencies in individual RT reactions. This cDNA 
was diluted 1 in 10 with nuclease free water, and 4 ul (containing 10 ng of cDNA) was 
used in subsequent qPCR. 
 
Quantitative real-time polymerase chain reaction 
To confirm induction of downstream targets of each stimulation, qPCR was performed 
on the CFX Connect Real-Time System (Bio-Rad, Hercules, CA) using 4 μL of cDNA, 4 μL 
of iQ SYBRGreen Supermix (Bio-Rad), 1.5 μL each of 20 uM forward and reverse primers 















Amplification consisted of: a pre-cycling hold at 95 °C for 5 minutes; 40 cycles of 
denaturation for 30 seconds at 95 °C; annealing for 30 seconds at 60 °C; extension for 30 
seconds at 72 °C; and a post-extension hold at 72 °C for 1 second. A melting curve was 
produced by a 1-second hold at every 0.5 °C between 70 °C and 95 °C to confirm a single 
PCR amplicon. For each primer set, standard curves were generated with serially diluted 
amplicon to confirm an efficiency of at least 85%. Amplicon size was confirmed by 
electrophoresis on 2% agarose gel. Cycle threshold was measured with Cq 
determination mode set to regression. Relative expression was calculated in the Gene 
Expression Analysis module of CFX Manager v3.1 (Bio-Rad), which uses the 2-ΔΔCt 
method,13 normalizing to three reference genes that were stable for the specific 
condition and human donor by the criteria described below. Results corresponding to 
individual control and stimulated conditions were compared statistically by two-tailed 
Student’s t-test, and a significant difference between conditions was defined as one 
yielding a p-value less than 0.05.  
 
Quantitative real-time polymerase chain reaction array  
The qPCR arrays were performed with two PrimePCR Pathway Plates: Reference Genes 
H96 and Reference Genes Plus H96 (BioRad). Each of these plates contains validated and 
optimized primer pairs for 14 human reference gene transcripts in triplicate test and 
control samples (Supplementary Table 2), as well as primer pairs for detection of 
genomic DNA contamination, and for verifying cDNA quality and performance efficiency 
of qPCR. The manufacturer’s instructions were followed exactly, including the use of 
SsoAdvanced Universal SYBR Green Supermix (Bio-Rad) and 4 μl (10 ng) of cDNA per 
reaction. The qPCR plates were run on CFX96 Connect Real-Time PCR Detection System, 















minutes; 40 cycles of denaturation at 95 ˚C for 5 seconds; annealing/extension at 60˚C 
for 30 seconds; and production of a melt curve from 65 ˚C to 95 ˚C, in 0.5 ˚C increments, 
for 5 seconds at each temperature.   
 
Reference gene expression was evaluated using the Gene Expression Analysis module of 
CFX Manager v3.1, as described above. The qBase program14 implemented within this 
module was used to calculate a gene-stability measure – or M-value – and a coefficient of 
variation – or CV-value – for each reference gene, by condition and donor. The M-value 
of a reference gene is the mean pairwise variation – defined as standard deviation of 
logarithm expression ratios – for that gene, in comparison to other reference genes 
tested for the same samples.15 Thus, relatively a low M-value equates with more stable 
expression. The CV-value represents a comparison of normalized relative quantities of 
reference gene across samples.14 Like the M-value, a relatively low CV-value indicates 
stability of expression. The CV- and M-values for each reference gene in the two retinal 
endothelial isolates and six conditions were ranked numerically. By applying stringent 
cut-offs of CV-value less than 0.1 and M-value less than 0.2, stably expressed reference 





Comparison of reference gene expression by human retinal endothelial cells treated with 
molecular or microbial stimuli  
Two retinal endothelial cell lines established from paired eyes of two human cadaveric 















used to study cell responses in disease: glucose at supraphysiological concentration; 
DMOG; VEGFA; TNF-α; LPS; and T. gondii tachyzoites; or medium alone as control for 
each treatment. All stimuli elicited significant increases in transcripts encoding known 
targets over baseline conditions, as determined by RT-qPCR, indicating biological 
responses by cells to all treatments: glucose, 2.3- and 1.6-fold increase in IL-1β 
transcript; DMOG, 7.8- and 18.8-fold increase in VEGFA transcript; VEGFA, 3.9- and 4.5-
fold increase in DSCR1 transcript; TNF-α, 21.0- and 75.4-fold increase in ICAM-1 
transcript; LPS, 12.5- and 12.7-fold increase in ICAM-1 transcript; and T. gondii 
tachyzoites, 6.4- and 8.6-fold increase in SOCS1 transcript (Figure 1).  
 
Expression of 28 reference genes in stimulated versus control retinal endothelial cells 
was investigated by qPCR array, using two PrimePCR Pathway Plates, each spotted with 
primer pairs for 14 human reference gene transcripts in triplicate. The expression of 27 
of the 28 reference genes was calculated as fold-difference for each molecular or 
microbial treatment relative to medium alone, following normalization to: PSMC4, IPO8 
and SDHA (glucose); RPL13A, YWHAZ and G6PD (DMOG); HSP90AB1, UBC and HPRT1 
(VEGFA); HSP90AB1, PSMC4 and ACTB (TNF-α); GAPDH, GUSB and YWHAZ (LPS); SDHA, 
ALAS1 and GUSB (T. gondii tachyzoites). The final reference gene, HBB, was removed 
from this analysis, based on PCR cycle threshold values that exceeded 35, indicating 
minimal to no expression in human retinal endothelial cells. Comparison of fold-changes 
revealed substantial differences in reference gene expression across stimulations. For 
the retinal endothelial cell line generated for donor 1, expression of reference genes 
varied: 0.5- to 1.1-fold for glucose at supraphysiological concentration, 0.8- to 1.7-fold 
for DMOG, 0.8- to 1.2-fold for VEGFA; 0.8- to 1.4-fold for TNF-α, 0.9 to 1.5-fold for LPS, 















line generated for donor 2, expression of reference genes varied: 0.8- to 1.3-fold for 
glucose at supraphysiological concentration, 0.04- to 1.7-fold for DMOG, 0.7- to 18.6-fold 
for VEGFA; 0.7- to 1.5-fold for TNF-α, 0.9- to 1.6-fold for LPS, and 0.8- and 1.3-fold for T. 
gondii tachyzoites (Figure 3). This comparison also revealed differences in reference 
gene expression between human retinal endothelial cell lines. Largest differences were 
observed for: LDHA under conditions of DMOG stimulation (1.70-fold versus 0.04-fold); 
RPLP0 under conditions of VEGFA stimulation (1.0-fold versus 18.6-fold); and GADPH 
under conditions of VEGFA stimulation (0.9-fold versus 4.3-fold), for retinal endothelial 
cell lines of donors 1 and 2, respectively. 
 
Analysis of stability of reference gene expression in human retinal endothelial cells treated 
with molecular or microbial stimuli  
Expression stability of reference genes in human retinal endothelial cells across 
stimulated and control conditions was assessed by M- and CV-values. Applying stringent 
criteria of CV-value less than 0.1 and M-value less than 0.2, we identified reference genes 
that demonstrated stable expression in retinal endothelial cell lines from the two human 
donors, under the six different conditions. By these criteria, overall 11-21 of 28 
reference genes (41-78%) maintained expression stability following treatments, across 
stimuli and human retinal endothelial cell lines. For glucose at supraphysiological 
concentration, 22 and 14 references genes were stable by CV-value, and 25 and 13 
references genes were stable by M-value in the two cell lines: 11 reference genes were 
stable by both criteria in each line (Table 1). For DMOG, 17 and 13 references genes 
were stable by CV-value, and 13 and 10 references genes were stable by M-value in the 
two cell lines: 11 reference genes were stable by both criteria in each line (Table 2). For 















genes were stable by M-value in the two cell lines: 17 and 15 reference genes were 
stable by both criteria (Table 3). For TNF-α, 21 and 16 references genes were stable by 
CV-value, and 22 and 15 references genes were stable by M-value in the two cell lines: 
14 reference genes were stable by both criteria in each line (Table 4). For LPS, 18 and 21 
references genes were stable by CV-value in the two cell lines, and 22 references genes 
were stable by M-value in each line: 21 and 16 reference genes were stable by both 
criteria (Table 5). For T. gondii tachyzoites, 20 and 19 references genes were stable by 
CV-value, and 18 and 24 references genes were stable by M-value, and in the two cell 
lines: 17 and 18 reference genes were stable by both criteria (Table 6). 
 
Comparison of stable reference gene expressed in human retinal endothelial cells under 
different conditions of stimulation and by donor 
Ranking of reference genes expressed in human retinal endothelial cells by lowest M- 
and CV-values for the two cell lines, indicated substantial diversity in the most stably 
expressed reference genes under different conditions of stimulation (Tables 1-6, 
summarized in Table 7). For glucose at supra-physiological concentration, the most 
stably expressed reference genes were PSMC4, IPO8 and SDHA. For DMOG, the most 
stably expressed reference genes were RPL13A, YWHAZ, GUSB and HPRT1. For VEGFA, 
the most stably expressed reference genes were HSP90AB1, UBC and HPRT1. For LPS, 
the most stably expressed reference genes were GAPDH, GUSB, YWHAZ and RPLP0. For 
TNF-α, the most stably expressed reference genes were HSP90AB1, PSMC4, and ACTB. 
For T. gondii tachyzoites, the most stably expressed reference genes were SDHA, ALAS1 
and GUSB. Overall, no reference gene was expressed stably under all six conditions of 
stimulation for both donors. Fourteen reference genes were expressed stably under 3 or 















PSMC4 and RPLPO); 6 reference genes under 4 conditions (i.e., ACTB, B2M, GUSB, RPL30, 
SDHA and YWHAZ); and 6 reference genes under 3 conditions (i.e., ALAS1, GAPDH, 




Use of multiple stably expressed reference genes is a key implication of the MIQE 
guidelines. Two surveys conducted since the publication of these recommendations in 
2009, reviewing diverse studies that used RT-qPCR in over 1700 articles, indicated 
normalization procedures were inadequate in the majority of published works.16 Indeed, 
the authors of these surveys highlighted “the problem of a huge body of literature that 
reports conclusions that may be meaningless and will cause research resources to be 
wasted”.  
 
We identified articles published between 2009 and 2015 that described RT-qPCR 
studies involving human retinal endothelial cells specifically, using the National Library 
of Medicine of National Institutes of Health PubMed database (Figure 4, Table 9 and 
Supplementary Table 3). Our search yielded a total of 72 publications: the number of 
publications increased over time from 2 in 2009 to 23 in 2015.  Consistent with current 
understanding of the pathogenesis of common retinal diseases, investigations most 
commonly involved treatment of human retinal endothelial cells with: glucose or 
advanced glycation end-products; hypoxia, hypoxia mimics or VEGF; and inflammatory 
stimuli. Overall, studies in just one of the 72 articles employed more than one reference 
gene, and stability of reference gene expression was reported in only one article also.  















GAPDH (21 articles). This analysis of the relevant literature indicates that researchers 
performing RT-qPCR studies involving human retinal endothelial cells often do not 
follow the MIQE recommendations.  
 
We used PCR array profiling to evaluate the potential application of 28 reference genes 
in RT-qPCR studies of human retinal endothelial cells. We examined reference gene 
expression in response to six stimuli, which are commonly used to elicit disease-
relevant responses, in two retinal endothelial cell lines separately derived from eyes of 
two human donors, and we observed variation in expression of reference genes across 
stimuli and cell lines. Multiple statistical algorithms have been developed to evaluate the 
stability of reference genes in qPCR; a comparison of different methodologies indicates 
medium to high correlation.17 For this reason, and for real-world applicability, we chose 
to assess reference gene stability with two widely utilized measures – M-value and CV-
value – and we set relatively stringent limits. Our investigation identified 10-15 of 28 
reference genes (36-54%) expressed stably across different stimulated and control 
conditions. The group of stably expressed reference genes varied with condition, and no 
reference gene was stably expressed under every condition, although 4 of the 28 were 
stable for 5 of 6 conditions (i.e., HSP90AB1, IPO8, PSCM4 and RPLP0). Of direct relevance 
to published studies of human retinal endothelial cells, ACTB transcript was stable to 
treatments with DMOG, VEGFA, TNF-α and LPS, but not glucose and T. gondii 
tachyzoites, while GAPDH transcript was stable to treatments with TNF-α, LPS and T. 
gondii tachyzoites, but not glucose, DMOG and VEGFA. 
 
Two independent groups have evaluated reference gene stability in human retinal 















endothelial cells with polyinosinic:polycytidylic acid, which activates innate immune 
responses via toll-like receptor 3, and evaluated expression of 10 reference genes by  
RT-qPCR. The authors identified HPRT1, TBP and PGK1 as the most stably expressed 
reference genes in that setting. Consistently, we observed stability of one or two of the 
same reference genes in human retinal cells treated with other immune mediators, TNF-
α, LPS and T. gondii. Xie et al19 studied expression stability of 14 reference genes in 
human retinal endothelial cells treated with glucose at supraphysiological concentration 
and/or hypoxia by RT-qPCR. The investigators found an alternative group of reference 
genes to be most stably expressed: TBP, PUM1 and ALAS1. We also observed ALAS1 
transcript level to be unaffected by treatment with highly concentrated glucose. 
However, none of these three molecules was represented in our list of stable reference 
genes in cells treated with the hypoxia mimic, DMOG. Reference gene expression has 
been studied in other endothelial cell populations, including human umbilical vein and 
brain endothelial cells, treated with metabolic and inflammatory stimuli.20-22 In each of 
these studies, different groups of reference genes were stably expressed, including 
ACTB, ALAS1, GAPDH, GUSB, RPLP0, RALBP1, RNU6-1 and TFRC. Interestingly, TFRC, 
which was represented on the PCR array we used, was not expressed stably under any 
treatment condition we studied. 
 
Studies in different cell populations have identified a variety of experimental conditions, 
other than stimulations, that may impact reference gene expression stability. The time 
over which a stimulation is applied may alter the expression of reference gene 
transcripts substantially.23 Confluence of cells in culture may lead to changes in levels of 
reference genes,24 and the physical properties of the substrate on which cells are grown 















invariably display a range of responses to the same stimulus, and this is often reflected 
at the cellular level, in studies of gene expression by human cells, the possibility of inter-
individual variation in expression of reference genes is often not considered. Previously 
we have demonstrated phenotypic differences in human retinal endothelial cell isolates 
from different donors by molecular profiling, as well as studies of function.2,26,27 In this 
current work, we observed differences in the expression stability of reference genes 
between retinal endothelial cell lines, generated from two human donors, for each of the 
six disease-associated stimuli that we tested. 
 
Human retinal endothelial cells are being employed increasingly in studies of retinal 
vascular diseases, and many of these investigations are undertaken with an ultimate 
goal of developing new treatments. For such research, the importance of accurately 
normalized RT-qPCR data cannot be understated. Our work provides a guide to 
reference genes that may be suitable for normalization in RT-qPCR studies of human 
retinal endothelial cells subjected to different pathological stimuli. More importantly, 
however, our work highlights the variation in expression stability of reference genes 
that may be encountered with different stimuli and between human retinal endothelial 
cell isolates. Our findings provide strong evidence that researchers, who work in this 
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Figure 1. Expression of target molecules by human retinal endothelial cell lines 
following stimulation with: (A) glucose at supraphysiological concentration; (B) 
dimethyloxalylglycine (DMOG); (C) vascular endothelial growth factor (VEGFA); (D) 
tumor necrosis factor (TNF)-α; (E) lipopolysaccharide (LPS); and (F) Toxoplasma gondii 
tachyzoites, or medium alone. Three stable reference gene transcripts were applied for 
normalization of each result: ALAS1, SDHA and UBC (glucose); B2M, RPLP0 and YWHAZ 
(DMOG, VEGFA and T. gondii tachyzoites); ACTB, PPIA and RPLP0 (TNF-α); and ACTB, 
GAPDH and YWHAZ (LPS). Bars represent mean relative expression, with error bars 
showing standard error of the mean. n = 3 cultures/condition. Data were analyzed by 
two-tailed Student’s t-test. IL-1β = interleukin 1β; DSCR1 = Down syndrome critical 
region gene 1 (DSCR1); ICAM-1 = intercellular adhesion molecule 1; SOCS1 = 

















Figure 2. Expression of 27 reference genes by human retinal endothelial cell line 1 
following treatments with: glucose at supraphysiological concentration; dimethyloxalyl-
glycine (DMOG); vascular endothelial growth factor (VEGFA); tumor necrosis factor 
(TNF)-α; lipopolysaccharide (LPS); and Toxoplasma gondii tachyzoites. Three stable 
reference gene transcripts were applied for normalization of each result: PSMC4, IPO8 
and SDHA (glucose); RPL13A, YWHAZ and G6PD (DMOG); HSP90AB1, UBC and HPRT1 
(VEGFA); HSP90AB1, PSMC4 and ACTB (TNF-α); GAPDH, GUSB and YWHAZ (LPS); and 
SDHA, ALAS1 and GUSB (T. gondii tachyzoites). Colored bars represent mean expression 
by stimulated cells, calculated relative to expression by cells exposed to medium alone. 
Black error bars show standard error of the mean. n = 3 cultures/condition. Full names 

















Figure 3. Expression of 27 reference genes by human retinal endothelial cell line 2 
following treatments with: glucose at supraphysiological concentration; dimethyloxalyl-
glycine (DMOG); vascular endothelial growth factor (VEGFA); tumor necrosis factor 
(TNF)-α; lipopolysaccharide (LPS); and Toxoplasma gondii tachyzoites. Three stable 
reference gene transcripts were applied for normalization of each result: PSMC4, IPO8 
and SDHA (glucose); RPL13A, YWHAZ and G6PD (DMOG); HSP90AB1, UBC and HPRT1 
(VEGFA); HSP90AB1, PSMC4 and ACTB (TNF-α); GAPDH, GUSB and YWHAZ (LPS); and 
SDHA, ALAS1 and GUSB (T. gondii tachyzoites). Colored bars represent mean expression 
by stimulated cells, calculated relative to expression by cells exposed to medium alone. 
Black error bars show standard error of the mean. n = 3 cultures/condition. Full names 
















Figure 4. Number of articles published annually between 2009 and 2015, inclusive, 
which have reported studies of human retinal endothelial cells using RT-qPCR, as listed 
in the National Library of Medicine of National Institutes of Health PubMed database 
(www.ncbi.nlm.nih.gov/pubmed; search date = 28 February, 2017; search text = human 

















Table 1. Reference genes expressed by human retinal endothelial cells following 
treatment with glucose at supraphysiological concentration. Genes are ordered by 
coefficient of variation (CV) and gene-stability measure (M) (lowest to highest, 
indicating decreasing stability), calculated by comparison with control cells treated with 
medium alone (n = 3 samples/condition). Red indicates reference genes that were stably 
expressed according to CV-value below 0.1 or M-value below 0.2. Yellow highlight 
indicates reference genes that were stably expressed according to CV-value below 0.1 
and M-value below 0.2, for both cell lines. Full names of reference genes with 
abbreviations appear in Supplementary Table 2. 
 
 
Coefficient of variation (CV) 
 
 
Gene-stability measure (M) 
 
Cell line 1 
 
 
Cell line 2 
 
Cell line 1 
 






















PSMC4 0.0004 PSMC4 0.0016 RPL13A 0.075 PSMC4 0.0555 
RPS18 0.0022 SDHA 0.0052 RPS18 0.075 SDHA 0.0563 
RPL13A 0.0055 CDKN1A 0.0091 RPLP0 0.0766 IPO8 0.0573 
RPLP0 0.0095 HSP90AB1 0.011 PGK1 0.0769 ALAS1 0.0574 
RPL30 0.013 IPO8 0.0171 HPRT1 0.0818 CDKN1A 0.0577 
PGK1 0.0143 ALAS1 0.0174 TBP 0.082 HSP90AB1 0.0588 
TBP 0.0217 PPIH 0.0365 GUSB 0.088 PPIH 0.069 
UBC 0.025 UBC 0.0393 UBC 0.0909 UBC 0.0713 
HPRT1 0.0252 NONO 0.0444 IPO8 0.0912 NONO 0.087 
IPO8 0.0272 G6PD 0.0501 RPL30 0.0924 RPL30 0.088 
SDHA 0.0299 RPL30 0.0547 NONO 0.0925 PUM1 0.1013 
GUSB 0.0307 PUM1 0.0648 PSMC4 0.0969 LDHA 0.117 
NONO 0.0307 LDHA 0.0721 B2M 0.0976 PPIA 0.1401 
HSP90AB1 0.0399 PPIA 0.0895 PPIH 0.1067 RPL13A 0.3229 
B2M 0.0489 ACTB 0.1052 ALAS1 0.1111 GUSB 0.3229 
PPIH 0.0543 RPS18 0.1167 HMBS 0.1127 HPRT1 0.323 
ALAS1 0.0595 TBP 0.119 GAPDH 0.1129 TBP 0.3297 
HMBS 0.0659 RPL13A 0.1495 SDHA 0.1151 RPS18 0.3307 
GAPDH 0.0661 GUSB 0.1525 HSP90AB1 0.1235 ACTB 0.3384 
G6PD 0.0741 HPRT1 0.1529 G6PD 0.1266 PGK1 0.3401 
YWHAZ 0.0761 PGK1 0.191 YWHAZ 0.1288 GAPDH 0.3491 
CDKN1A 0.0917 RPLP0 0.1961 CDKN1A 0.146 HMBS 0.3789 
PUM1 0.1018 GAPDH 0.2042 PUM1 0.1594 B2M 0.3843 
TFRC 0.1116 HMBS 0.237 TFRC 0.1737 G6PD 0.3875 
ACTB 0.123 B2M 0.2417 ACTB 0.1915 TFRC 0.4147 
PPIA 0.1277 TFRC 0.2638 PPIA 0.2189 RPLP0 0.6622 

















Table 2. Reference genes expressed by human retinal endothelial cells following 
treatment with dimethyloxalylglycine. Genes are ordered by coefficient of variation (CV) 
and gene-stability measure (M) (lowest to highest, indicating decreasing stability), 
calculated by comparison with control cells treated with medium alone (n = 3 
samples/condition). Red indicates reference genes that were stably expressed according 
to CV-value below 0.1 or M-value below 0.2. Yellow highlight indicates reference genes 
that were stably expressed according to CV-value below 0.1 and M-value below 0.2, for 
both cell lines. Full names of reference genes with abbreviations appear in 
Supplementary Table 2. 
 
 
Coefficient of variation (CV) 
 
 
Gene-stability measure (M) 
 
Cell line 1 
 
 
Cell line 2 
 
Cell line 1 
 






















YWHAZ 0.0049 HPRT1 0.0064 RPL13A 0.0838 G6PD 0.1106 
PPIH 0.0144 RPL13A 0.0084 TFRC 0.0838 RPS18 0.1106 
RPL13A 0.016 GUSB 0.0106 B2M 0.0843 YWHAZ 0.1121 
TFRC 0.016 HSP90AB1 0.0307 HPRT1 0.085 RPLP0 0.1145 
GUSB 0.0183 G6PD 0.0327 YWHAZ 0.0884 GUSB 0.1155 
B2M 0.0185 RPS18 0.0379 GUSB 0.0944 HPRT1 0.1174 
G6PD 0.0187 YWHAZ 0.0449 G6PD 0.0946 B2M 0.1194 
HPRT1 0.02 RPLP0 0.0501 RPS18 0.0995 RPL13A 0.1272 
SDHA 0.0225 B2M 0.0576 RPLP0 0.1044 ACTB 0.1277 
IPO8 0.0239 ACTB 0.0668 ACTB 0.1321 TBP 0.1401 
RPLP0 0.0297 TBP 0.078 GAPDH 0.1459 TFRC 0.2042 
RPS18 0.0418 TFRC 0.095 HMBS 0.1481 GAPDH 0.2072 
GAPDH 0.0671 GAPDH 0.0977 TBP 0.1706 HMBS 0.2529 
ACTB 0.0784 HMBS 0.1621 PUM1 0.2325 PGK1 0.5385 
HSP90AB1 0.0845 ALAS1 0.1732 HSP90AB1 0.2325 PSMC4 0.6563 
HMBS 0.0928 PSMC4 0.1769 ALAS1 0.2372 IPO8 0.6563 
PUM1 0.0956 PPIA 0.2178 PSMC4 0.2382 ALAS1 0.6572 
TBP 0.1096 IPO8 0.2215 IPO8 0.2459 NONO 0.6701 
ALAS1 0.1169 NONO 0.2817 SDHA 0.2466 RPL30 0.6724 
PSMC4 0.1192 RPL30 0.2866 RPL30 0.2588 PUM1 0.718 
RPL30 0.1497 PGK1 0.3398 PPIH 0.2712 SDHA 0.7189 
NONO 0.1639 PUM1 0.3516 NONO 0.2715 HSP90AB1 0.7208 
PPIA 0.1763 SDHA 0.3525 PPIA 0.2855 UBC 0.7749 
CDKN1A 0.2211 UBC 0.3994 CDKN1A 0.3463 PPIA 0.8874 
UBC 0.2463 PPIH 0.4672 PGK1 0.3955 PPIH 1.1235 
PGK1 0.2519 CDKN1A 0.7222 UBC 0.4793 CDKN1A 1.4694 


















Table 3. Reference genes expressed by human retinal endothelial cells following 
treatment with vascular endothelial growth factor. Genes are ordered by coefficient of 
variation (CV) and gene-stability measure (M) (lowest to highest, indicating decreasing 
stability), calculated by comparison with control cells treated with medium alone (n = 3 
samples/condition). Red indicates reference genes that were stably expressed according 
to CV-value below 0.1 or M-value below 0.2. Yellow highlight indicates reference genes 
that were stably expressed according to CV-value below 0.1 and M-value below 0.2, for 
both cell lines. Full names of reference genes with abbreviations appear in 
Supplementary Table 2. 
 
 
Coefficient of variation (CV) 
 
 
Gene-stability measure (M) 
 
Cell line 1 
 
 
Cell line 2 
 
Cell line 1 
 






















TBP 0.0004 PUM1 0.0048 GUSB 0.0657 PSMC4 0.1376 
HSP90AB1 0.0049 SDHA 0.0092 HPRT1 0.0657 IPO8 0.1376 
UBC 0.0053 RPL30 0.0105 TBP 0.067 HSP90AB1 0.1381 
HPRT1 0.0061 HSP90AB1 0.0112 RPLP0 0.0679 RPL30 0.1384 
LDHA 0.0115 PSMC4 0.0135 ACTB 0.0743 SDHA 0.1392 
GUSB 0.0117 GUSB 0.0198 RPS18 0.0788 NONO 0.1409 
RPLP0 0.0216 RPL13A 0.0203 G6PD 0.0807 PPIA 0.1511 
NONO 0.0275 HPRT1 0.0263 HMBS 0.0826 PUM1 0.1517 
G6PD 0.0306 IPO8 0.0331 GAPDH 0.0885 UBC 0.1684 
HMBS 0.0334 YWHAZ 0.0433 RPL13A 0.0974 YWHAZ 0.1735 
ACTB 0.036 RPS18 0.0453 HSP90AB1 0.0997 HPRT1 0.1735 
PSMC4 0.0364 NONO 0.048 UBC 0.0997 B2M 0.1769 
IPO8 0.0382 B2M 0.0588 LDHA 0.1011 CDKN1A 0.1798 
PPIH 0.041 RPLP0 0.0696 B2M 0.1067 RPLP0 0.1817 
RPS18 0.0427 PPIA 0.0709 NONO 0.1069 GUSB 0.1837 
GAPDH 0.0536 ALAS1 0.0798 YWHAZ 0.1075 RPL13A 0.184 
YWHAZ 0.0614 ACTB 0.0915 PSMC4 0.1109 ACTB 0.1963 
RPL13A 0.0616 UBC 0.0968 IPO8 0.113 LDHA 0.1993 
CDKN1A 0.0676 CDKN1A 0.1096 PPIH 0.1148 RPS18 0.2006 
B2M 0.0686 GAPDH 0.1099 TFRC 0.1214 PPIH 0.2074 
TFRC 0.0739 HMBS 0.1185 CDKN1A 0.1385 HMBS 0.2205 
RPL30 0.0792 LDHA 0.1271 RPL30 0.1394 ALAS1 0.2351 
SDHA 0.081 PPIH 0.1331 SDHA 0.141 GAPDH 0.2582 
ALAS1 0.0852 G6PD 0.1619 ALAS1 0.1581 G6PD 0.2691 
PGK1 0.1029 TFRC 0.1942 PGK1 0.1602 TFRC 0.3528 
PUM1 0.11 PGK1 0.2346 PUM1 0.1734 PGK1 0.3679 


















Table 4. Reference genes expressed by human retinal endothelial cells following 
treatment with tumor necrosis factor-alpha. Genes are ordered by coefficient of 
variation (CV) and gene-stability measure (M) (lowest to highest, indicating decreasing 
stability), calculated by comparison with control cells treated with medium alone (n = 3 
samples/condition). Red indicates reference genes that were stably expressed according 
to CV-value below 0.1 or M-value below 0.2. Yellow highlight indicates reference genes 
that were stably expressed according to CV-value below 0.1 and M-value below 0.2, for 
both cell lines. Full names of reference genes with abbreviations appear in 
Supplementary Table 2. 
 
 
Coefficient of variation (CV) 
 
 
Gene-stability measure (M) 
 
Cell line 1 
 
 
Cell line 2 
 
Cell line 1 
 






















RPS18 0.0009 ALAS1 0.0126 ACTB 0.0821 ALAS1 0.1358 
PUM1 0.0016 ACTB 0.0179 RPLP0 0.0821 PSMC4 0.1358 
HSP90AB1 0.0057 PSMC4 0.0228 GUSB 0.0826 HSP90AB1 0.1382 
PSMC4 0.0092 TFRC 0.0232 RPS18 0.0845 PUM1 0.1395 
RPLP0 0.0097 HSP90AB1 0.0234 G6PD 0.0886 PPIA 0.1443 
RPL30 0.0098 GAPDH 0.0286 GAPDH 0.0895 RPL30 0.1455 
G6PD 0.0103 RPLP0 0.0302 TBP 0.1019 LDHA 0.152 
ACTB 0.012 PPIA 0.0371 RPL13A 0.1184 IPO8 0.1524 
GUSB 0.0141 RPL30 0.0389 HPRT1 0.1233 ACTB 0.1662 
SDHA 0.0208 PUM1 0.0396 HMBS 0.1343 GAPDH 0.1662 
GAPDH 0.0297 HPRT1 0.044 YWHAZ 0.1376 RPLP0 0.1666 
NONO 0.0455 LDHA 0.0677 PGK1 0.159 HPRT1 0.1727 
IPO8 0.0478 IPO8 0.0683 PUM1 0.1641 TFRC 0.1753 
TBP 0.0482 TBP 0.0818 HSP90AB1 0.1641 PPIH 0.1864 
LDHA 0.0523 RPL13A 0.0847 PSMC4 0.1648 SDHA 0.1981 
PPIA 0.0529 GUSB 0.0951 RPL30 0.1666 RPL13A 0.1999 
HPRT1 0.0622 SDHA 0.098 SDHA 0.1715 TBP 0.2014 
RPL13A 0.0668 YWHAZ 0.1053 TFRC 0.1831 NONO 0.2035 
PPIH 0.0716 PPIH 0.1065 LDHA 0.1839 GUSB 0.2091 
YWHAZ 0.0783 NONO 0.1218 NONO 0.1879 YWHAZ 0.2171 
HMBS 0.0811 G6PD 0.1406 IPO8 0.19 G6PD 0.2486 
PGK1 0.0975 PGK1 0.1721 PPIA 0.1956 PGK1 0.2841 
TFRC 0.1176 UBC 0.1833 PPIH 0.1969 UBC 0.2864 
B2M 0.1298 RPS18 0.1891 B2M 0.2022 RPS18 0.3146 
ALAS1 0.1705 HMBS 0.2398 ALAS1 0.2853 HMBS 0.3762 
CDKN1A 0.2121 CDKN1A 0.2637 CDKN1A 0.3324 CDKN1A 0.4145 


















Table 5. Reference genes expressed by human retinal endothelial cells following 
treatment with Escherichia coli 055:B5 lipopolysaccharide. Genes are ordered by 
coefficient of variation (CV) and gene-stability measure (M) (lowest to highest, 
indicating decreasing stability), calculated by comparison with control cells treated with 
medium alone (n = 3 samples/condition). Red indicates reference genes that were stably 
expressed according to CV-value below 0.1 or M-value below 0.2. Yellow highlight 
indicates reference genes that were stably expressed according to CV-value below 0.1 
and M-value below 0.2, for both cell lines. Full names of reference genes with 
abbreviations appear in Supplementary Table 2. 
 
 
Coefficient of variation (CV) 
 
 
Gene-stability measure (M) 
 
Cell line 1 
 
 
Cell line 2 
 
Cell line 1 
 






















YWHAZ 0.0002 RPLP0 0.0002 GAPDH 0.081 RPS18 0.0807 
GUSB 0.0035 PGK1 0.002 YWHAZ 0.081 TBP 0.0807 
PSMC4 0.0066 GAPDH 0.0051 GUSB 0.0817 ACTB 0.0823 
HSP90AB1 0.0083 RPL30 0.0102 ACTB 0.0858 GAPDH 0.0827 
GAPDH 0.0149 RPS18 0.0143 HPRT1 0.0868 GUSB 0.0845 
HPRT1 0.0149 TBP 0.0146 RPS18 0.0896 RPLP0 0.0851 
LDHA 0.0181 HSP90AB1 0.0191 HMBS 0.0924 PGK1 0.0863 
PPIH 0.0229 ACTB 0.0216 RPLP0 0.0934 YWHAZ 0.0922 
RPLP0 0.0249 IPO8 0.0248 B2M 0.098 RPL13A 0.1083 
IPO8 0.0254 GUSB 0.0266 TBP 0.0982 G6PD 0.1241 
ALAS1 0.0305 RPL13A 0.0268 PGK1 0.1052 HMBS 0.1295 
UBC 0.0322 LDHA 0.0295 PSMC4 0.1332 HSP90AB1 0.1419 
ACTB 0.0365 YWHAZ 0.0381 HSP90AB1 0.1332 RPL30 0.1419 
PGK1 0.0381 PPIH 0.0392 IPO8 0.137 IPO8 0.1432 
RPS18 0.0451 B2M 0.0617 LDHA 0.1387 LDHA 0.1452 
HMBS 0.0494 NONO 0.0645 PPIH 0.1408 B2M 0.1471 
PUM1 0.0544 SDHA 0.0664 ALAS1 0.1458 PPIH 0.1529 
B2M 0.0556 G6PD 0.074 UBC 0.1474 SDHA 0.165 
TBP 0.0558 HMBS 0.0789 PUM1 0.1499 NONO 0.1686 
NONO 0.1034 ALAS1 0.0839 RPL13A 0.1668 HPRT1 0.1703 
RPL13A 0.1071 PSMC4 0.0933 NONO 0.1826 ALAS1 0.1766 
G6PD 0.1096 UBC 0.096 G6PD 0.1847 PSMC4 0.185 
RPL30 0.111 PUM1 0.1084 RPL30 0.1894 UBC 0.1967 
PPIA 0.1423 HPRT1 0.1094 PPIA 0.2244 PUM1 0.2018 
SDHA 0.1536 PPIA 0.1503 SDHA 0.2397 PPIA 0.2574 
TFRC 0.1724 CDKN1A 0.255 TFRC 0.2692 CDKN1A 0.4005 


















Table 6. Reference genes expressed by human retinal endothelial cells following 
treatment with GT-1 strain Toxoplasma gondii tachyzoites. Genes are ordered by 
coefficient of variation (CV) and gene-stability measure (M) (lowest to highest, 
indicating decreasing stability), calculated by comparison with control cells treated with 
medium alone (n = 3 samples/condition). Red indicates reference genes that were stably 
expressed according to CV-value below 0.1 or M-value below 0.2. Yellow highlight 
indicates reference genes that were stably expressed according to CV-value below 0.1 
and M-value below 0.2, for both cell lines. Full names of reference genes with 
abbreviations appear in Supplementary Table 2. 
 
 
Coefficient of variation (CV) 
 
 
Gene-stability measure (M) 
 
Cell line 1 
 
 
Cell line 2 
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GUSB 0.002 ALAS1 0.0051 PSMC4 0.1263 GAPDH 0.0813 
RPLP0 0.0096 SDHA 0.009 NONO 0.1263 GUSB 0.0813 
PGK1 0.0283 GUSB 0.0092 PPIA 0.1263 HMBS 0.0829 
HSP90AB1 0.0403 YWHAZ 0.0094 SDHA 0.1267 YWHAZ 0.0854 
RPS18 0.0443 GAPDH 0.01 AL S1 0.1313 TBP 0.0855 
SDHA 0.0465 PSMC4 0.0119 IPO8 0.1339 B2M 0.0864 
NONO 0.0484 UBC 0.0144 RPL30 0.1393 HPRT1 0.0924 
PSMC4 0.0555 HMBS 0.0171 RPS18 0.147 RPLP0 0.0987 
PPIA 0.0555 TBP 0.023 GAPDH 0.147 ALAS1 0.1079 
RPL13A 0.0598 NONO 0.0234 B2M 0.1499 PSMC4 0.1079 
GAPDH 0.0605 B2M 0.0243 PGK1 0.1506 UBC 0.1084 
HPRT1 0.0643 HPRT1 0.0252 YWHAZ 0.1509 SDHA 0.1087 
ALAS1 0.0667 RPLP0 0.0345 PUM1 0.153 NONO 0.1124 
IPO8 0.0706 RPL30 0.042 RPLP0 0.1589 PGK1 0.1189 
B2M 0.0735 PGK1 0.0609 G6PD 0.161 RPL30 0.1234 
YWHAZ 0.0757 RPS18 0.0694 HMBS 0.1635 RPS18 0.1297 
RPL30 0.0767 HSP90AB1 0.0729 HSP90AB1 0.1653 HSP90AB1 0.1454 
PUM1 0.089 IPO8 0.0784 GUSB 0.1666 RPL13A 0.1468 
G6PD 0.0909 RPL13A 0.0848 ACTB 0.18 IPO8 0.1476 
HMBS 0.0937 G6PD 0.0912 PPIH 0.2069 G6PD 0.1526 
PPIH 0.1027 PUM1 0.0933 RPL13A 0.2179 PUM1 0.1609 
ACTB 0.1084 PPIA 0.1155 HPRT1 0.223 PPIA 0.1834 
UBC 0.1541 CDKN1A 0.1186 UBC 0.2404 CDKN1A 0.1869 
TBP 0.1583 PPIH 0.1209 TBP 0.247 PPIH 0.1918 
CDKN1A 0.1616 LDHA 0.1363 CDKN1A 0.2597 LDHA 0.2124 
LDHA 0.1687 ACTB 0.1391 LDHA 0.2677 ACTB 0.2168 



















Table 7. Reference genes that demonstrated stable expression in human retinal 
endothelial cells following treatment with: glucose at supraphysiological concentration; 
dimethyloxalylglycine (DMOG); vascular endothelial growth factor (VEGFA); tumor 
necrosis factor (TNF)-α; lipopolysaccharide (LPS); and Toxoplasma gondii tachyzoites, 
as determined by gene-stability measure below 0.2 and coefficient of variation below 
0.1, and ranked according to expression stability. Full names of reference genes with 





















1 PSMC4 RPL13A HSP90AB1 HSP90AB1 GAPDH SDHA 
2 IPO8 YWHAZ, 
GUSB, 
HPRT1 
UBC PSMC4 GUSB ALAS1 
3 SDHA G6PD HPRT1 ACTB YWHAZ, 
RPLP0 
GUSB 











GAPDH HSP90AB1 YWHAZ 
7 RPL30 ACTB RPL30 RPL30 TBP B2M 
8 NONO - RPL13A PPIA IPO8 PGK1 
9 PPIH - SDHA HPRT1 LDHA HMBS 
10 CDKN1A - YWHAZ LDHA HMBS RPS18 
11 - - ACTB IPO8 PPIH RPL30 
12 - - B2M SDHA PSMC4 IPO8 
13 - - - RPL13A B2M HSP90AB1 
14 - - - - ALAS1 PUM1 

















Table 8. Reference genes demonstrating consistent expression stability in human retinal 
endothelial cells across treatments (ie. glucose at supraphysiological concentration; 
dimethyloxalyl-glycine (DMOG); vascular endothelial growth factor (VEGFA); tumor 
necrosis factor (TNF)-α; lipopolysaccharide (LPS); and Toxoplasma gondii tachyzoite), as 
determined by gene-stability measure below 0.2 and coefficient of variation below 0.1. 























Stable in 5 conditions 
 
HSP90AB1       
IPO8       
PSMC4       
RPLPO       
 
Stable in 4 conditions 
 
ACTB       
B2M       
GUSB       
RPL30       
SDHA       
YWHAZ       
 
Stable in 3 conditions 
 
ALAS1       
GAPDH       
HPRT1       
RPL13A       
RPS18       


















Table 9. Use of reference genes in RT-qPCR studies of human retinal endothelial cells in 
72 articles published between 2009 and 2015 on the National Library of Medicine of 
National Institutes of Health PubMed database (www.ncbi.nlm.nih.gov/pubmed; search 
date = 28 February, 2017; search text = human retinal endothelial cell; languages filter = 
English). Some articles reported works that involved multiple treatments. Articles are 






















> 1 1 
 
NR Yes NR 
Glucose/AGE 25 18S rRNA, ACTB, GAPDH, HPRT1, 
U6 snRNA 
0 24 1 0 25 
Hypoxia & 
hypoxic mimics 
6 ACTB, GAPDH 0 5 1 0 6 
VEGF 
 
8 ACTB, GAPDH 0 8 0 0 8 




8 18S rRNA, ACTB, GAPDH, HPRT1 0 6 0 0 6 
Microbial mimics 
 
3 GAPDH, HPRT1, PGK1, TBP 1 2 0 1 2 
Enzymes 
 
2 18S rRNA, HPRT1 0 2 0 0 2 
Lipids 
 
2 18S rRNA, GAPDH, PPIA 0 2 0 0 2 
Transfection of 
nucleic acid 
8 18S rRNA, ACTB, GAPDH 0 8 0 0 8 
Drugs & 
chemicals 
9 ACTB, GAPDH, PPIA 0 9 0 0 9 
Shear stress 
 
2 GAPDH 0 2 0 0 2 
No treatment 
 
3 ACTA, GAPDH, HPRT1 0 3 0 0 3 
Abbreviations: AGE = advanced glycation end-products, VEGF = vascular endothelial growth 
factor, NR = not recorded. Full names of reference genes with abbreviations appear in 


















 We investigated reference gene expression in human retinal endothelial cells  
 
 Gene expression varied substantially across stimulations and between cell lines 
 

















ACTB: Actin beta 
ALAS1: Aminoerulinate, delta-synthase 1 
B2M: Beta-2-microglobulin 
DMEM: Dulbecco’s modified Eagle’s medium 
DMOG: Dimethyloxalylglycine 
DSCR1: Down syndrome critical region gene 1 
FBS: Fetal bovine serum 
G6PD: Glucose-6-phophate dehydrogenase 
GAPDH: Glyceraldehyde-3-phophate dehydrogenase 
GUSB: Glucuronidase beta 
HBB: Hemoglobin, beta 
HMBS: Hydroxymethylbilane synthase 
HPRT1: Hypoxanthine phosphoribosyltransferase 1 
HSP90AB1: Heat shock protein 90kDA (cytosolic), Class B member 1 
ICAM-1: Intercellular adhesion molecule 1 
IL-1β: Interleukin 1β 
IPO8: Importin 8 
LDHA: Lactate dehydrogenase A 
LPS: Lipopolysaccharide 
MIQE: Minimum information for publication of qPCR experiments 
NONO: Non-POU domain containing, octamer-binding 
p21, Cip1: Cyclin-dependent kinase inhibitor 1A 
PGK1: Phosphoglycerate kinase 1 
PPIA: Peptidyl isomerase A (cyclophilin A) 
PPIH: Peptidyl isomerase H (cyclophilin H) 
PSMC4: Proteasome 26S subunit, ATPase 4 
PUM1: Pumilio RNA-binding family member 1 
RPL13A: Ribosomal protein L13a 
RPL30: Ribosomal protein L30 
RPLP0: Ribosomal protein, large, P0 
RPS18: Ribosomal protein S18 
RT-qPCR: Reverse transcription-quantitative real-time polymerase chain reaction 















SOCS1: Suppressor of cytokine signaling 1 
TBP: TATA box binding receptor 
TFRC: Transferrin receptor  
TNF-α: Tumor necrosis factor α 
UBC: Ubiquitin C 
VEGFA: Vascular endothelial growth factor 
YWHAZ: Tyrosine 3-mono-oxygenase/tryptophan 5-mono-oxygenase activation protein zeta 
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